Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_assertion type Assertion NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_head.
- NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_assertion description "[Because of the restricted expression of mRNA in B cell-lineage cells, IRTA2 is a new potential target for the immunotherapy of B cell malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_provenance.
- NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_assertion evidence source_evidence_literature NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_provenance.
- NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_assertion SIO_000772 15671532 NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_provenance.
- NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_assertion wasDerivedFrom befree-20140225 NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_provenance.
- NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_assertion wasGeneratedBy ECO_0000203 NP682784.RAM9g3X7pAMIXCxArnFX1aYb5edcGxjRIa2hiM_HPhVIc130_provenance.